FDA Recalls Chlorthalidone Tablets Over Dissolution Issues
The FDA has announced a recall of chlorthalidone tablets after over 13,000 bottles failed critical dissolution tests, impacting their effectiveness.
The FDA has announced a recall of chlorthalidone tablets after over 13,000 bottles failed critical dissolution tests, impacting their effectiveness.